Medicare proposes anemia drug coverage limits (Reuters)
Reuters - The U.S. Medicare health insurance
program proposed limiting payments for Amgen Inc. and Johnson &
Johnson anemia drugs on Monday in response to safety concerns.
Original post by stephend
You must be logged in to post a comment.